Thyroid cancer. Malignant neoplasm of thyroid gland
Conditions
Interventions
Intervention 1: Intervention group: Initially, all patients in the intervention group will complete a needs assessment and questionnaires. The intervention will be provided in (2-5) 60-90 minute sessi
Sponsors
Yasouj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Over 18 years old Patients who have undergone Thyroidectomy Patients whose Iodine therapy has ended or who are not currently receiving Iodine therapy (Will not be receiving Iodine therapy in the next one or two months) People should have the ability to use cyberspace and mobile phones Have consent to participate in the study Thyroid cancer has been confirmed by a doctor People should have the ability to communicate and answer questions
Exclusion criteria
Exclusion criteria: Patients with cognitive impairment and dementia and mental illness Lack of study inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fatigue status score obtained from the Cancer Fatigue Questionnaire (Okuyama et al., 2000). Timepoint: Before the start of the intervention, immediately after the end of the intervention, three months after the end of the intervention. Method of measurement: Cancer Fatigue Questionnaire (Okuyama et al., 2000).;Total Quality of life score obtained from the Cancer Patients Quality of Life Questionnaire, European Organization for Research and Treatment of Cancer(version 3). Timepoint: Before the start of the intervention, immediately after the end of the intervention, three months after the end of the intervention. Method of measurement: Quality of life Questionnaire of cancer patients, European Organization for Research and Treatment of Cancer(version 3). | — |
Secondary
| Measure | Time frame |
|---|---|
| Physical fatigue score obtained from questions (1, 2, 3, 6, 9, 12, 15) of the Cancer Fatigue Questionnaire (Okuyama et al., 2000). Timepoint: Before the start of the intervention, immediately after the end of the intervention, three months after the end of the intervention. Method of measurement: Cancer Fatigue Questionnaire (Okuyama et al., 2000).;Emotional fatigue score obtained from questions (5, 8, 11, 14) of the Cancer Fatigue Questionnaire (Okuyama et al., 2000). Timepoint: Before the start of the intervention, immediately after the end of the intervention, three months after the end of the intervention. Method of measurement: Cancer Fatigue Questionnaire (Okuyama et al., 2000).;Cognitive fatigue score obtained from questions (4, 7, 10, 13) of the Cancer Fatigue Questionnaire (Okuyama et al., 2000). Timepoint: Before the start of the intervention, immediately after the end of the intervention, three months after the end of the intervention. Method of measurement: Cancer Fatigue Questionnaire (Okuyama et al., 2000).;Physical function score of quality of life obtained from questions (1, 2, 3, 4, 5) of the Cancer Patients Quality of Life Questionnaire, European Organization for Research and Treatment of Cancer (Version 3). Timepoint: Before the start of the intervention, immediately after the end of the intervention, three months after the end of the intervention. Method of measurement: Cancer Patients' Quality of Life Questionnaire, European Organization for Research and Treatment of Cancer (Version 3).;Role performance score of quality of life obtained from questions (6, 7) of the Cancer Patients Quality of Life Questionnaire, European Organization for Research and Treatment of Cancer (Version 3). Timepoint: Before the start of the intervention, immediately after the end of the intervention, three months after the end of the intervention. Method of measurement: Cancer Patients' Quality of Life Questionnaire, European Organization for Research and Treatment of C | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Nazafarin Hosseini
Yasouj University of Medical Sciences
Outcome results
None listed